Article

Shoes for ovarian cancer research

Olive Palermo shoes by Stuart Weitzman

With Breast Cancer Awareness Month already in full swing a little early, it's nice to see that September is still getting "tealed" for Ovarian Cancer Awareness Month. While cause-related marketing has become increasingly mainstream, this campaign did catch my eye. And no, I'm not a huge shoe fan. I'm more of sneakers and flip-flop kind of girl, but it was fun wondering if I'm more of a Hayden Panettiere or Olivia Palermo.

Olivia Palermo design; photo credit Stuart WeitzmanStuart Weitzman co-developed the series of shoes with four young starlets for "Young Hollywood Cares." You can view the other designs at stuartweitzman.com.Instead of stating that proceeds go to "research and awareness," as many fundraisers tend to do, all proceeds from the shoes will go directly to fund ovarian cancer research by Dr. Marsha Moses, director of the Vascular Biology Program at Children's Hospital Boston and professor at Harvard Medical School. Moses specializes in angiogenesis, a process where blood vessels grow to feed a tumor. There are numerous therapies - both approved and in development - that aim to inhibit the signals and pathways involved in angiogenesis. Here's to hoping that Scarlett Johansson's designer shoes help Dr. Moses find a breakthrough. And it just might - all four of the designers shoes are already sold out - and we still have one more week left of Ovarian Cancer Awareness Month. Too bad they didn't have a teal pair.

Related Videos
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Related Content